Studies Linking GLP-1 Medications to NAION Several peer-reviewed studies have confirmed an increased risk of NAION in patients taking GLP-1 drugs: Harvard Medical School & Mass General Brigham Study (JAMA Ophthalmology, 2024) 9% of diabetic patients taking semaglutide developed NAION, compared to 1.8% on other diabetes drugs (a 4-fold increased risk)
Nghin cu cng khng nh sau 14h kh nng hp thu ca Omega 3 s b gim i
PlexusDx breaks down what you need to know before starting GLP-1 therapy post-thyroidectomy
Semaglutide induces weight loss via two primary mechanisms
So while clinical research might be in the pipeline, there is ample evidence from users worldwide about the positive effects of BPC-157 when it comes to its effects on the gut-brain axis, musculoskeletal healing, and recovery
But you may be able to control it with medicine, gentle skin care and avoiding things that cause flare-ups